Selected Key Figures*

The fiscal year of HELLA ends on May 31.

* Please observe the remarks on the Yearly Figures.

Yearly figures

in € million	2016/2017	2015/2016	2014/2015
Sales	6,585	6,352	5,835
Change compared to previous period [curency- and portfolio adjusted]	4% [4%]	9% [8%]	9% [7%]
EBIT [adjusted]	507 [534]	420 [476]	430 [445]
Change compared to previous period	21% [12%]	-2% [7%]	24% [12%]
EBITDA [adjusted]	919 [946]	816 [858]	766 [781]
Change compared to previous period	13% [10%]	7% [10%]	17% [10%]
Earning for the period	343	272	295
Change compared to previous period	26%	-8%	29%
Earnings per share (in €)	3.08	2.42	2.70
Change compared to previous period	27%	-11%	21%
R&D expenses	636	623	544
Change compared to previous period	2%	15%	6%
Free Cashflow [adjusted]	69 [149]	76 [155]	142 [158]
Net capital expediture	517	463	347

EBIT margin [adjusted]	7.7% [8.1%]	6.6% [7.5%]	7.4% [7.6%]
EBITDA margin [adjusted]	14.0% [14.4%]	12.8% [13.5%]	13.1% [13.4%]
R&D expenses in relation to sales	9.7%	9.8%	9.3%
Net financial debt	278	238	131
Net financial debt/EBITDA (last 12 months)	0.3x	0.3x	0.2x
Equity ratio	39.5%	39.6%	38.8%
Return on equity (last 12 months)	17.3%	14.2%	22.0%
Number of employees (headcount)	37,716	33,689	31,864

For further informations, please refer to the Consolidated Financial Statement

in € million	9 Months FY 2017/2018	9 Months FY 2016/2017
Sales	5,130	4,776
Change compared to previous period [curency- and portfolio adjusted]	7% [9%]	3% [3%]
EBIT [adjusted]	404 [408]	348 [373]
Change compared to previous period	16% [9%]	20% [8%]
EBITDA [adjusted]	733 [737]	641 [666]
Change compared to previous period	14% [11%]	10% [7%]
Earning for the period	277	248
Change compared to previous period	12%	35%
Earnings per share (in €)	2.48	2.21
Change compared to previous period	12%	35%
R&D expenses	510	468
Change compared to previous period	9%	4%
Free Cashflow from operating activities [adjusted]	145 [166]	29 [106]
Net capital expediture	312	328
Change compared to previous period	-5%	10%

EBIT margin [adjusted]	7.9% [8.0%]	7.3% [7.8%]
EBITDA margin [adjusted]	14.3% [14.4%]	13.4% [13.9%]
R&D expenses in relation to sales	9.9%	9.8%
Net capital expediture in relation to sales	6.1%	6.9%

	28. Feb 18	31. May 17
Net financial debt	250	278
Net financial debt/EBITDA (last 12 months)	0.2x	0.3x
Equity ratio	41.7%	39.5%
Return on equity (last 12 months)	17.1%	17.3%
Number of employees (headcount)	40,064	37,716

Further information can be found in the selected financial information and in the further notes.

in € million	3^rd Quarter FY 2017/2018	3^rd Quarter FY 2016/2017
Sales	1,678	1,578
Change compared to previous period [curency- and portfolio adjusted]	6% [9%]	6% [6%]
EBIT [adjusted]	114 [115]	103 [105]
Change compared to previous period	11% [10%]	18% [17%]
EBITDA [adjusted]	228 [229]	203 [205]
Change compared to previous period	13% [12%]	11% [11%]
Earnings for the period	78	74
Change compared to previous period	5%	41%
Earnings per share (in €)	0.70	0.65
Change compared to previous period	7%	38%
R&D expenses	171	157
Change compared to previous period	9%	0%
Free cashflow from operating activities [adjusted]	72 [75]	29 [32]
Net capital expenditure	99	120
Change compared to previous period	-17%	11%

EBIT margin [adjusted]	6.8% [6.9%]	6.5% [6.6%]
EBITDA margin	13.6% [13.7%]	12.9% [13.0%]
R&D expenses in relation to sales	10.2%	9.9%
Net capital expediture in relation to sales	5.9%	7.6%